MEK inhibition enhances gemcitabine efficacy by increasing MDM2-mediated ubiquitination and degradation of RRM1

被引：0
|
作者：
Vena, F. [1 ]
Li Causi, E. [2 ]
Hagemann, T. [2 ]
Hartley, J. A. [1 ]
Goodstal, S. [3 ]
Hochhauser, D. [1 ]
机构：
[1] UCL, UCL Canc Inst, London, England
[2] Barts Canc Inst, London, England
[3] EMD Serono, Res Inst, Billerica, MA USA
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/S0959-8049(14)70571-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
445
引用
收藏
页码：146 / 146
页数：1
相关论文
共 50 条
  • [31] LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation
    Zeng, Kaixuan
    Chen, Xiaoxiang
    Hu, Xiuxiu
    Liu, Xiangxiang
    Xu, Tao
    Sun, Huiling
    Pan, Yuqin
    He, Bangshun
    Wang, Shukui
    ONCOGENE, 2018, 37 (41) : 5534 - 5551
  • [32] The nucleolar SUMO-specific protease SMT3IP1/SENP3 attenuates Mdm2-mediated p53 ubiquitination and degradation
    Nishida, Tamotsu
    Yamada, Yoshiji
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 406 (02) : 285 - 291
  • [33] FOXO1 promotes cancer cell growth through MDM2-mediated p53 degradation
    Tomiyasu, Haruki
    Habara, Makoto
    Hanaki, Shunsuke
    Sato, Yuki
    Miki, Yousei
    Shimada, Midori
    CANCER SCIENCE, 2025, 116 : 232 - 232
  • [34] FOXO1 promotes cancer cell growth through MDM2-mediated p53 degradation
    Tomiyasu, Haruki
    Habara, Makoto
    Hanaki, Shunsuke
    Sato, Yuki
    Miki, Yosei
    Shimada, Midori
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2024, 300 (04)
  • [35] BAI1 Suppresses Medulloblastoma Formation by Protecting p53 from Mdm2-Mediated Degradation
    Zhu, Dan
    Osuka, Satoru
    Zhang, Zhaobin
    Reichert, Zachery R.
    Yang, Liquan
    Kanemura, Yonehiro
    Jiang, Ying
    You, Shuo
    Zhang, Hanwen
    Devi, Narra S.
    Bhattacharya, Debanjan
    Takano, Shingo
    Gillespie, G. Yancey
    Macdonald, Tobey
    Tan, Chalet
    Nishikawa, Ryo
    Nelson, William G.
    Olson, Jeffrey J.
    Van Meir, Erwin G.
    CANCER CELL, 2018, 33 (06) : 1004 - +
  • [36] Correction: LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation
    Kaixuan Zeng
    Xiaoxiang Chen
    Xiuxiu Hu
    Xiangxiang Liu
    Tao Xu
    Huiling Sun
    Yuqin Pan
    Bangshun He
    Shukui Wang
    Oncogene, 2021, 40 : 3772 - 3773
  • [37] Epstein-Barr Virus Nuclear Antigen 3C Augments Mdm2-Mediated p53 Ubiquitination and Degradation by Deubiquitinating Mdm2 (vol 83, pg 4652, 2009)
    Saha, Abhik
    Murakami, Masanao
    Kumar, Pankaj
    Bajaj, Bharat
    Sims, Karen
    Robertson, Erle S.
    JOURNAL OF VIROLOGY, 2021, 95 (17)
  • [38] Hyperhomocysteinemia activates NLRP3 inflammasome to cause hepatic steatosis and insulin resistance via MDM2-mediated ubiquitination of HSF1
    Xiang, Wenjing
    Yang, Yang
    Weng, Liangkun
    Ye, Zhiming
    Ding, Ping
    Li, Huayu
    Sun, Jia
    Zeng, Cheng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 118
  • [39] Epigallocatechin gallate promotes p53 accumulation and activity via the inhibition of MDM2-mediated p53 ubiquitination in human lung cancer cells
    Jin, Longyu
    Li, Cui
    Xu, Yan
    Wang, Li
    Liu, Jianxin
    Wang, Dianjun
    Hong, Cao
    Jiang, Zhibing
    Ma, Yuchao
    Chen, Qian
    Yu, Fenglei
    ONCOLOGY REPORTS, 2013, 29 (05) : 1983 - 1990
  • [40] Core Binding Factor β Protects HIV, Type 1 Accessory Protein Viral Infectivity Factor from MDM2-mediated Degradation
    Matsui, Yusuke
    Shindo, Keisuke
    Nagata, Kayoko
    Yoshinaga, Noriyoshi
    Shirakawa, Kotaro
    Kobayashi, Masayuki
    Takaori-Kondo, Akifumi
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (48) : 24892 - 24899
12345